Literature DB >> 8752292

Host factors associated with protection against rotavirus disease: the skies are clearing.

P A Offit1.   

Abstract

Over the past several years, a number of studies have clarified aspects of rotavirus immunology and vaccinology previously considered controversial. In this review, studies that address the following questions will be summarized: Which host factors are responsible for recovery from acute rotavirus infection? Are the host factors responsible for recovery from acute infection the same as those necessary for prevention of infection? What is the relative importance of the nature of the inoculum (e.g., homologous or heterologous host virus and live or inactivated virus), route of inoculation, or virus serotype in vaccine development? What is the immunologic basis by which infection with 1 viral serotype protects against challenge with another serotype (heterotypic protection)?

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752292     DOI: 10.1093/infdis/174.supplement_1.s59

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Rotavirus Vaccines: Current Controversies and Future Directions.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

2.  Isolation of human monoclonal antibodies that neutralize human rotavirus.

Authors:  Kyoko Higo-Moriguchi; Yasushi Akahori; Yoshitaka Iba; Yoshikazu Kurosawa; Koki Taniguchi
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population.

Authors:  Serenella Arista; Giovanni M Giammanco; Simona De Grazia; Stefania Ramirez; Concetta Lo Biundo; Claudia Colomba; Antonio Cascio; Vito Martella
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

4.  Primary murine small intestinal epithelial cells, maintained in long-term culture, are susceptible to rotavirus infection.

Authors:  K K Macartney; D C Baumgart; S R Carding; J O Brubaker; P A Offit
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

5.  Sequence analysis demonstrates that VP6, NSP1 and NSP4 genes of Indian neonatal rotavirus strain 116E are of human origin.

Authors:  N A Cunliffe; B K Das; M Ramachandran; M K Bhan; R I Glass; J R Gentsch
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

6.  Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).

Authors:  E L Ford-Jones; S Calvin
Journal:  Can Commun Dis Rep       Date:  2010-11-30

7.  Selection of single-chain antibodies against the VP8* subunit of rotavirus VP4 outer capsid protein and their expression in Lactobacillus casei.

Authors:  Vicente Monedero; Jesús Rodríguez-Díaz; Rosa Viana; Javier Buesa; Gaspar Pérez-Martínez
Journal:  Appl Environ Microbiol       Date:  2004-11       Impact factor: 4.792

8.  Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates.

Authors:  Xiaobo Wen; Dianjun Cao; Ronald W Jones; Jianping Li; Shousun Szu; Yasutaka Hoshino
Journal:  Vaccine       Date:  2012-08-09       Impact factor: 3.641

9.  Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.

Authors:  Carl D Kirkwood; Karen Boniface; Simone Richardson; Zenobia F Taraporewala; John T Patton; Ruth F Bishop
Journal:  J Med Virol       Date:  2008-06       Impact factor: 2.327

10.  Cytokines as mediators for or effectors against rotavirus disease in children.

Authors:  B Jiang; L Snipes-Magaldi; P Dennehy; H Keyserling; R C Holman; J Bresee; J Gentsch; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  2003-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.